Tushar Pandey: From ITP to TTP in Clinical Practice
Tushar Pandey, Director and Head of Raghav Institute of Hematology, Hemato-Oncology and BMT at Raghav Healthcare, Editorial Board Member at Journal of Cancer Chemotherapy, Program Director of Hemato – Oncology at International Association For Integrated Oncology, shared a post on LinkedIn:
“Always a pleasure to speak about thrombocytopenia, especially ITP and TTP.
These conditions are commonly seen but still challenge clinicians due to their changing presentations, evolving evidence, and the need for timely and accurate decision-making.
From immune thrombocytopenia (ITP), where individualized treatment and long-term disease control are essential, to thrombotic thrombocytopenic purpura (TTP), a true hematologic emergency requiring rapid recognition and intervention, they reflect the complexity of real – world hematology practice.
Each opportunity like this helps bridge guidelines with real – life practice, ensuring patients receive evidence – based, practical, and life – saving care.
Grateful to contribute to the advancement of hematology, hemato-oncology, and BMT through knowledge sharing and clinical excellence.”
Stay updated with Hemostasis Today.
-
Oct 24, 2026, 16:42Mark-Anthony Johnson: Blood Type Awareness and Emergency Transfusion
-
Oct 24, 2026, 16:27Pedro Perez: Florida’s Push to Strengthen VTE Prevention
-
Oct 24, 2026, 16:23Kathleen Freson: Human Cell Models Advance Research into Rare Platelet Disorders
-
Oct 24, 2026, 16:18Victor Daniel: Deep Learning for Automated Platelet Classification
-
Oct 24, 2026, 16:08Paula Alonso-Frías: Human Umbilical Cord Blood Platelet-Rich Plasma for Endometrial Regeneration
-
Oct 24, 2026, 16:00Fatma Ebeid: Ain Shams University Hosts TIF Experts for Collaborating Center Evaluation
-
Oct 24, 2026, 15:52Mazen A. Juratli: Platelet-Derived Extracellular Vesicles as Potential Predictors of Survival in Liver Cancer
-
Oct 24, 2026, 14:28Satyam Arora: Umbilical Cord Blood for Neonatal Transfusions
-
Oct 24, 2026, 13:24Amelia Carro Hevia: Ischaemic Stroke Risk in Atrial Flutter vs Atrial Fibrillation